Sign Up Today and Learn More About Jupiter Endovascular Stock
Invest in or calculate the value of your shares in Jupiter Endovascular or other pre-IPO companies through EquityZen's platform.
Jupiter Endovascular Stock
Jupiter Endovascular is a medical technology startup.
About Jupiter Endovascular Stock
Founded
2024
Headquarters
Menlo Park, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Jupiter Endovascular Press Mentions
Stay in the know about the latest news on Jupiter Endovascular
Jupiter Endovascular Announces Positive Results From SPIRARE I First-in-human Study Presented at TCT 2025
businesswire • Oct 26, 2025
Jupiter Endovascular Announces Positive Results From SPIRARE I First-in-human Study Presented at TCT 2025
morningstar • Oct 26, 2025
Jupiter Endovascular Secures $40 Million in Series B Funding
globallegalchronicle • Oct 14, 2025
Jupiter Endovascular Secures Oversubscribed Funding to Advance TFX Technology
venturecapital • Oct 09, 2025
Jupiter Endovascular Completes Series B Round
vcnewsdaily • Oct 09, 2025
Jupiter Endovascular Management
Leadership team at Jupiter Endovascular
Founder & Board Member
Alex Tilson
CSO
Chuck Love
Join now and verify your accreditation status to gain access to:
- Jupiter Endovascular Current Valuation
- Jupiter Endovascular Stock Price
- Jupiter Endovascular Management
- Available deals in Jupiter Endovascular and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Jupiter Endovascular Cap Table and Funding History by Share Class and Liquidity Preferences
- Jupiter Endovascular Revenue and Financials
- Jupiter Endovascular Highlights
- Jupiter Endovascular Business Model
- Jupiter Endovascular Risk Factors
- Jupiter Endovascular Research Report from SACRA Research
Trading Jupiter Endovascular Stock
How to invest in Jupiter Endovascular stock?
Accredited investors can buy pre-IPO stock in companies like Jupiter Endovascular through EquityZen funds. These investments are made available by existing Jupiter Endovascular shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Jupiter Endovascular stock?
Shareholders can sell their Jupiter Endovascular stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."